Found: 3477
Select item for more details and to access through your institution.
Survival Probability in Multidrug Resistant Pulmonary Tuberculosis Patients in a South Indian Region.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 4, p. 427, doi. 10.1177/00185787231224065
- By:
- Publication type:
- Article
A Case to Support the Continued Use of Rifampin in Clinical Drug–Drug Interaction Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 34, doi. 10.1002/cpt.3256
- By:
- Publication type:
- Article
Assessment of polymeric mucin–drug interactions.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0306058
- By:
- Publication type:
- Article
Silent Case of Pediatric Osteoarticular Tuberculosis: A Case Report and Review of the Literature.
- Published in:
- Clinical Medicine Insights: Case Reports, 2024, p. 1, doi. 10.1177/11795476241263683
- By:
- Publication type:
- Article
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1680, doi. 10.1093/cid/ciae119
- By:
- Publication type:
- Article
Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1698, doi. 10.1093/cid/ciae145
- By:
- Publication type:
- Article
Trends of Mycobacterium tuberculosis and rifampicin resistance at the Ho Teaching Hospital in Ghana.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0305161
- By:
- Publication type:
- Article
Species prevalence, virulence genes, and antibiotic resistance of enterococci from food-producing animals at a slaughterhouse in Turkey.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63984-y
- By:
- Publication type:
- Article
Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited Settings.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2415576, doi. 10.1001/jamanetworkopen.2024.15576
- By:
- Publication type:
- Article
The (p)ppGpp synthetase Rsh promotes rifampicin tolerant persister cell formation in Brucella abortus by regulating the type II toxin-antitoxin module mbcTA.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2024.1395504
- By:
- Publication type:
- Article
Life-Threatening Stridor due to Laryngeal Tuberculosis in the COVID-19 Era: Report of a Case.
- Published in:
- ENT: Ear, Nose & Throat Journal, 2024, v. 103, p. 91S, doi. 10.1177/01455613211070896
- By:
- Publication type:
- Article
Effects of rifampicin on the pharmacokinetics and safety of carotegrast methyl in healthy subjects: A randomized 2 × 2 crossover study.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 6, p. 1395, doi. 10.1111/bcp.16024
- By:
- Publication type:
- Article
Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1336, doi. 10.1002/cpt.3215
- By:
- Publication type:
- Article
Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 590, doi. 10.1002/cpdd.1404
- By:
- Publication type:
- Article
The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 785, doi. 10.1007/s00228-024-03652-2
- By:
- Publication type:
- Article
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series.
- Published in:
- HIV Medicine, 2024, v. 25, n. 6, p. 754, doi. 10.1111/hiv.13632
- By:
- Publication type:
- Article
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 6, p. 1346, doi. 10.1093/jac/dkae105
- By:
- Publication type:
- Article
First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 6, p. 1353, doi. 10.1093/jac/dkae107
- By:
- Publication type:
- Article
Covalent functionalization of graphene oxide with l-lysine for highly sensitive and selective simultaneous electrochemical detection of rifampicin and acetaminophen.
- Published in:
- Journal of Applied Electrochemistry, 2024, v. 54, n. 6, p. 1379, doi. 10.1007/s10800-023-02031-6
- By:
- Publication type:
- Article
Fetal protective effect of Indonesian propolis from Apis mellifera against rifampicin-pyrazinamide induced impaired pregnancy in BALB/c mice.
- Published in:
- Journal of Complementary & Integrative Medicine, 2024, v. 21, n. 2, p. 197, doi. 10.1515/jcim-2023-0352
- By:
- Publication type:
- Article
Multidrug-Resistant Tuberculosis in the Child Presenting with ITP-like Clinic.
- Published in:
- Journal of Pediatric Infection / Çocuk Enfeksiyon Dergisi, 2024, v. 18, n. 2, p. e114, doi. 10.5578/ced.20240207
- By:
- Publication type:
- Article
Pattern of Mutations in Rifampicin Resistance (rpoB) Gene and Analysis of Rifampicin Indeterminate Result in Tuberculosis Detected by Xpert MTB/RIF Assay in Kalaburagi, India.
- Published in:
- Journal of Pure & Applied Microbiology, 2024, v. 18, n. 2, p. 1290, doi. 10.22207/JPAM.18.2.49
- By:
- Publication type:
- Article
Evaluation of a real-time PCR assay performance to detect Mycobacterium tuberculosis, rifampicin, and isoniazid resistance in sputum specimens: a multicenter study in two major cities of Indonesia.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2024.1372647
- By:
- Publication type:
- Article
Co-delivery of doxycycline and rifampicin using CdTe-labeled poly (lactic-co-glycolic) acid for treatment of Brucella melitensis infection.
- Published in:
- BMC Chemistry, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13065-024-01200-8
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1246, doi. 10.1093/cid/ciad700
- By:
- Publication type:
- Article
Long-Term Protective Effect of Tuberculosis Preventive Therapy in a Medium/High Tuberculosis Incidence Setting.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 5, p. 1321, doi. 10.1093/cid/ciae101
- By:
- Publication type:
- Article
A Patient With Pneumonia and Erythematous Skin Lesions.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Myeloid cell expression of CD200R is modulated in active TB disease and regulates Mycobacterium tuberculosis infection in a biomimetic model.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1360412
- By:
- Publication type:
- Article
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48077-8
- By:
- Publication type:
- Article
Bacterial cellulose-based scaffold: synthesis and surface modification for sustained rifampicin release for topic skin infections treatment.
- Published in:
- Cellulose, 2024, v. 31, n. 7, p. 4441, doi. 10.1007/s10570-024-05901-0
- By:
- Publication type:
- Article
Ditch the Itch: Propofol in the Management of Cholestatic Pruritus.
- Published in:
- Clinical Pediatrics, 2024, v. 63, n. 4, p. 580, doi. 10.1177/00099228231182821
- By:
- Publication type:
- Article
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Multidrug-Resistant Mycobacterium tuberculosis in Jiangxi, China.
- Published in:
- Infection & Drug Resistance, 2024, v. 17, p. 2213, doi. 10.2147/IDR.S460267
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 977, doi. 10.1093/jac/dkae057
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug‐Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 5, p. 590, doi. 10.1002/jcph.2385
- By:
- Publication type:
- Article
Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 5, p. 904, doi. 10.1111/jdv.19725
- By:
- Publication type:
- Article
Concomitant Treatment with Doxycycline and Rifampicin in Balb/c Mice Infected with Brucella abortus 2308 Fails to Reduce Inflammation and Motor Disability.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 5, p. 638, doi. 10.3390/ph17050638
- By:
- Publication type:
- Article
Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 4, p. 1043, doi. 10.1093/cid/ciad694
- By:
- Publication type:
- Article
A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1012137
- By:
- Publication type:
- Article
Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans.
- Published in:
- PLoS Neglected Tropical Diseases, 2024, v. 18, n. 4, p. 1, doi. 10.1371/journal.pntd.0011867
- By:
- Publication type:
- Article
Rifampicin-resistant tuberculosis: A global health dilemma.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 624, doi. 10.1002/psp4.13106
- By:
- Publication type:
- Article
Clinical assessment of momelotinib drug–drug interactions via CYP3A metabolism and transporters.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 4, p. 1, doi. 10.1111/cts.13799
- By:
- Publication type:
- Article
Clinical Pearl: Neonatal Tuberculosis: Epidemiology, Presentation, and Treatment.
- Published in:
- Neonatology Today, 2024, v. 19, n. 4, p. 176
- By:
- Publication type:
- Article
Predicting Drug-Drug Interactions Involving Rifampicin Using a Semi-mechanistic Hepatic Compartmental Model.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 4, p. 699, doi. 10.1007/s11095-024-03691-5
- By:
- Publication type:
- Article
Antimicrobial Resistance Patterns in Patients with Vaginal Discharge: A 2019-2022 Analysis at the National Health Laboratory in Eritrea.
- Published in:
- BioMed Research International, 2024, v. 2024, p. 1, doi. 10.1155/2024/7193490
- By:
- Publication type:
- Article
A synthesis of qualitative evidence of barriers and facilitators in implementing guidelines for TB testing in healthcare settings.
- Published in:
- Implementation Science Communications, 2024, v. 5, n. 1, p. 1, doi. 10.1186/s43058-024-00565-0
- By:
- Publication type:
- Article
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 514, doi. 10.1093/cid/ciad659
- By:
- Publication type:
- Article
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 702, doi. 10.1093/cid/ciad656
- By:
- Publication type:
- Article
Synthesis and Characterization of New N-acyl Hydrazone Derivatives of Carprofen as Potential Tuberculostatic Agents.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 212, doi. 10.3390/antibiotics13030212
- By:
- Publication type:
- Article
Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one‐stage exchange surgery protocol of implant‐associated osteomyelitis lesions in a porcine model.
- Published in:
- APMIS, 2024, v. 132, n. 3, p. 198, doi. 10.1111/apm.13371
- By:
- Publication type:
- Article